Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome
Background Psoriasis is a chronic immune-mediated hyperproliferative disease frequently associated with systemic comorbidities including metabolic syndrome (MS). Interleukin-17 (IL-17) has been identified as a central player in psoriasis-associated inflammation. Objective To investigate serum IL-17...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | |
| Опубликовано: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |